Journal
OTOLARYNGOLOGY-HEAD AND NECK SURGERY
Volume 150, Issue 3, Pages 407-412Publisher
WILEY
DOI: 10.1177/0194599813517081
Keywords
PEG tube; gastrostomy; head and neck cancer; nutrition
Categories
Ask authors/readers for more resources
ObjectiveTo understand the impact of percutaneous endoscopic gastrostomy (PEG) tube placement timing on tube duration, weight loss, and disease control in patients with head and neck cancer (HNC). SettingA tertiary academic center. Study DesignHistorical cohort study. Subjects and MethodsSeventy-four patients with HNC were reviewed. Patients underwent cisplatinum-based chemoradiation therapy with or without surgical resection. They received a PEG tube either before radiation therapy began (prophylactic) or after (reactive). Patients were matched on the basis of age, gender, TNM stage, tumor subsite, human papillomavirus (HPV) status, and chemoradiation dose. ResultsPatients receiving reactive PEG tubes had them in place for fewer days than those placed prophylactically (227 vs 139 days, P <. 01). There was no difference in percentage weight loss at 2, 6, or 12 months. There was no difference in survival or disease control between the groups. ConclusionsReactive PEG tube placement may afford patients a shorter duration of usage without incurring greater weight loss or poorer oncologic outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available